|Advanced Medical Solutions
||EPS - Basic
||Market Cap (m)
|Health Care Equipment & Services
Advanced Medical Solutions Share Discussion Threads
Showing 6926 to 6949 of 6950 messages
|If the results are as the trading statement would suggest, what share price are we looking to achieve after the results announcement ?|
|LOL ... Yes, I knew we made a glue gun ...|
|There, you see, it wasn't a "big step" :-)
|Thanks for clarifying ...|
I didn't know we made/supplied (hernia?) mesh ???|
Mr Steinmann was appointed as Non-Executive Director of AMS in July 2013. He is a Swiss national with over twenty years of commercial experience in Medical Devices and Diagnostics. He has held senior roles within Johnson & Johnson, Medtronic International and Boehringer Mannheim. Most recently, he was Regional Vice President Global Surgery and Shared Services, Medical Devices and Diagnostics, Austria, Germany and Switzerland at Johnson & Johnson AG, Switzerland as well as Chairman of the Board.
|J&J have has problems with mesh suppliers. They might well be interested.
|See Norbus (above) ....|
|Bit nerve-wracking this rise. Which way will it go medium term? I'm no chartist but a lower low does seem possible (if no news), as does a gap up to over 250 if the J&J and similar rumours hold the day.|
|Johnson& Johnson are buying; Good time to pick up AMS|
|Candlesticks charts suggest 'hammer' formed, which is positive after downtrend|
|I see little downside at these levels. It's come back with all of the pharmas.
last trading statement was the clue that AMS will benefit more from exchange rates this year than last because of their hedging policy.|
|A spirited discourse; In the old day's new products drove value. Now USA carrying the mantle. something has slowed down somewhere.|
|No problem. I enjoy hearing an alternative viewpoint also. I don't slavishly follow PEG ratios but they give me an idea whether I'm overpaying for growth. Totally useless for small cap stocks just emerging into profitability of course (or just at the start of a period of accelerating growth) - my main hunting ground.|
|Numbers can be erroneous, H. I use TD Direct information.
I cannot understand PEG - glamour ratio :-)
I think german success is the important issue.
Just realised, I thought this a long time ago!
Last increased in Feb. 16 at 160p.
Thanks for the viewpoint.|
Free Cash Flow yield: 4.46%
Quick Ratio: 4.4
Not wildly overpriced based on my numbers, H.
|It's been wildly overpriced for some time so a correction to be expected. Still very expensive.|
|Currency and EU sensitivity could be dictating the values.|
|Interesting pattern of buying.|
|Good solid trading statement today IMHO|
|The last set of interims were good but in my view probably put the share price ahead of where it should have been. So I feel the recent weakness to be about removing the froth and returning the price to a more realistic value for the growth potential. Having said that, AMS' share price has tended to lurch up and down from time to time but this feels a little more like a return to its historic trend.
200p might be about right for now.|
|Thanks cynic. Difficult to know but I agree with all your possibles. Still holding strong, may even buy.|